A changes
Pick any two versions below to diff them.
- Price
- $177.88 → $170.38(−4.2%)
- Discount category
- Pricey → Close to intrinsic value
- Recent events
- added: Nov 18, 2026: Agilent declared a quarterly dividend of $0.2625 per share, payable on January 27, 2027, to holders of record on January 5, 2027. The dividend before it was $0.255 per share, so the rate rose by about 2.9%. Nov 4, 2026: Agilent completed its purchase of Proscia, a maker of digital pathology software, according to press reports. Agilent announced the deal on October 13, 2026. It pays $240 million in cash and up to $30 million more if Proscia reaches future performance goals. Proscia had revenue of more than $18 million in the 12 months before the deal. Sep 4, 2026: Boon Hwee Koh retired as Chairperson of the Board after 23 years on the Board. The Board appointed Glenn Boehnlein, the former Chief Financial Officer of Stryker, as a director. Aug 26, 2026: Agilent reported Q3 fiscal year 2026 results. Revenue rose 8.1% to $1.88 billion, or 7.3% on a core basis, and non-GAAP EPS rose 18% to $1.62, with $0.06 from tariff refunds. Agilent raised its fiscal year 2026 guidance to revenue of $7.49 billion to $7.51 billion and non-GAAP EPS of $6.18 to $6.21. Jun 25, 2026: Agilent issued $600 million of 4.90% senior notes due January 2032. Jun 24, 2026: Agilent bought BC Midco I, Inc. (Biocare), a provider of clinical and research pathology products, for a net amount of $950 million. Biocare is part of the Life Sciences and Diagnostics Markets Group. Nov 24, 2025: Agilent reported fiscal year 2025 results. Revenue rose 6.7% to $6.95 billion, and non-GAAP EPS rose 6% to $5.59. Its first fiscal year 2026 guidance was revenue of $7.3 billion to $7.4 billion and non-GAAP EPS of $5.86 to $6.00.